In Africa, it’s more rational to prioritise vaccine access, rapid rollout and community engagement, than pushing the narrative of vaccine-induced population immunity.
Articles on Population immunity
Displaying all articles
When politicians and others speak about herd immunity, unfortunately, they are under the misconception that the current tools that we’ve got are adequate to eliminate the virus.
People in Canterbury have been told to be patient as their vaccination is delayed by weeks, but regional disparities in the vaccine rollout are unacceptable as we face new COVID-19 variants.
New Zealand will have to vaccinate 80-85% to reach population immunity. Until then, a blanket border re-opening, even if only for vaccinated people, would pose a high risk of new outbreaks.
Top contributors
-
Research Officer / EIDM Specialist, University of Cape Town
-
Senior Research Officer & Co-Director, Vaccines For Africa Initiative, Faculty of Health Sciences, University of Cape Town
-
Professor in Applied Mathematics, University of Canterbury
-
Associate Professor in Organisations and Leadership, University of Canterbury
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Research assistant, University of Auckland, Waipapa Taumata Rau
-
Adjunct professor, Te Herenga Waka — Victoria University of Wellington